Pfizer COVID Vaccine: FDA Could Grant Full Approval by Monday

A healthcare worker prepares a Pfizer coronavirus vaccination in Los Angeles, Calif., January 7, 2021. (Lucy Nicholson/Reuters)

The Food and Drug Administration is aiming to give full authorization to the Pfizer-BioNTech coronavirus vaccine by Monday, sources familiar with the matter told the New York Times on Friday.

All coronavirus vaccines currently offered in the U.S. — produced by Pfizer and BioNTech, Moderna, and Johnson & Johnson — currently have emergency authorization from the FDA. As of Friday, 62 percent of Americans, or about 205 million residents, have received one of the three vaccines with emergency authorization.

The granting of full approval of the Pfizer-BioNTech vaccine may give impetus to various public and private entities looking for greater approval from regulators to institute vaccination mandates.

The FDA declined to comment to the Times on the granting of full approval.

Send a tip to the news team at NR.

Zachary Evans is a news writer for National Review Online. He is a veteran of the Israeli Defense Forces and a trained violist.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button